TRIM47 and breast cancer: By analysis the TCGA published profiles of breast cancer, we found that overexpression of TRIM47 was not only associated with relapse-free survival time (P = 0.0031) but also with distant metastasis-free survival time (P = 0.0035) compared with lower TRIM47 expression in breast cancer patients (Fig. 1A).